학술논문
A nanotherapeutic strategy to target drug-tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer
Document Type
Letter
Author
Source
In: Cancer Communications . (Cancer Communications, April 2023, 43(4):503-507)
Subject
Language
English
ISSN
25233548